Editor’s Note: This interview was conducted at #BIO2018. Please pardon the background noise.
Chris Garabedian discusses his new compay, Xontogeny, a biotech aggregator with a differentiated business model to support the accelerated development of life science technologies in the pursuit of helping patients with serious diseases. Xontogeny partners with entrepreneurs, providing the leadership and operating experience needed to increase the probability of success with early drug and technology development.
